Health News

GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial

By Adria Calatayud GSK is moving a mRNA-based vaccine candidate for seasonal flu to a late-stage clinical trial after it achieved higher immune responses than rival …